QNTM

distress 8/10 · high distress / dilution risk

$2.850%today-90% from 52w high

quantumbiopharma.comFounded 1998Toronto, ONBiotechnology

Revenue

pre-revenue

Liquidity

$5M

Runway

0.6 yrs

Shares 1y

+172%

Price & events

-54.8% over 6M

CatalystRating changeDilutionFinancingdashed = today

-0.2%

-15.6%

-26.1%

-11.4%

-54.0%

-87.4%

-71.2%

-97.3%

All

Overview

Market Cap: $34
Volume: 24.82K
52 Week Range: $2.10 – $29.21
Total Shares: 12
Float Shares: 5.96M
Short %: 6.18%
% Held by Insiders: 12.36%
% Held by Institutions: 11.35%
RVOL: 0.19x
Beta: 0.44

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 12 · 2 offerings/1y · 0 PIPEs

2025-12-22424B5offering
2025-10-31424B5offering
2024-08-27424B5offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified